Massive study tests new migraine Pill's Real-World relief
NCT ID NCT06439628
Summary
This study is observing how well the medication rimegepant works for treating migraine attacks in everyday life. It will follow 3000 adults in China for up to a year to see how quickly it relieves pain, how satisfied people are with the relief, and if it helps them return to normal activities. The goal is to understand the medication's real-world effectiveness and long-term impact on quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhenjiang, China
Conditions
Explore the condition pages connected to this study.